Actively Recruiting
Time of Oxytocin Initiation at 2nd Stage of Labor and Adverse Outcomes
Led by Rambam Health Care Campus · Updated on 2023-12-26
120
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Early oxytocin administration at the 2nd stage of labor is associated with a higher rate of vaginal delivery, shorter second stage duration, and fewer adverse maternal and neonatal outcomes.
CONDITIONS
Official Title
Time of Oxytocin Initiation at 2nd Stage of Labor and Adverse Outcomes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Singleton pregnancy
- Maternal age �3E= 18 years old
- Oxytocin administration initiated or renewed during second stage of labor
You will not qualify if you...
- Maternal age < 18 years old
- Multiple gestation pregnancy
- Known fetal malformations
- Uterine scar
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Rambam medical health campus
Haifa, Israel, 31999
Actively Recruiting
Research Team
G
Gal Bachar, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here